These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 702058)

  • 1. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes.
    Lavie G; Zucker-Franklin D; Franklin EC
    J Exp Med; 1978 Oct; 148(4):1020-31. PubMed ID: 702058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired degradation of serum amyloid A (SAA) protein by cytokine-stimulated monocytes.
    Migita K; Yamasaki S; Shibatomi K; Ida H; Kita M; Kawakami A; Eguchi K
    Clin Exp Immunol; 2001 Mar; 123(3):408-11. PubMed ID: 11298127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elastase-type proteases on the surface of human blood monocytes: possible role in amyloid formation.
    Lavie G; Zucker-Franklin D; Franklin EC
    J Immunol; 1980 Jul; 125(1):175-80. PubMed ID: 6991601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of lysosomal enzymes and levels of serum amyloid A (SAA) in blood plasma of hamsters during casein induction of AA-amyloidosis.
    Hol PR; van Ederen AM; Snel FW; Langeveld JP; Veerkamp JH; Gruys E
    Br J Exp Pathol; 1985 Jun; 66(3):279-92. PubMed ID: 2860918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.
    Röcken C; Menard R; Bühling F; Vöckler S; Raynes J; Stix B; Krüger S; Roessner A; Kähne T
    Ann Rheum Dis; 2005 Jun; 64(6):808-15. PubMed ID: 15897303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Kupffer cell function precedes development of secondary amyloidosis.
    Fuks A; Zucker-Franklin D
    J Exp Med; 1985 May; 161(5):1013-28. PubMed ID: 3989470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of amyloid A protein by the cell lines from amyloid-susceptible and -resistant mice.
    Ham D; Skoryna SC
    Scand J Immunol; 2004 Feb; 59(2):117-22. PubMed ID: 14871287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of protein SAA to an AA-like fragment by enzymes of monocytic origin.
    Skogen B; Thorsteinsson L; Natvig JB
    Scand J Immunol; 1980; 11(5):533-40. PubMed ID: 6155692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assay of serum protein SAA in rhesus monkeys with secondary amyloidosis.
    Doepel FM; Glorioso JC; Newcomer CE; Skinner M; Abrams GD
    Lab Invest; 1981 Jul; 45(1):7-13. PubMed ID: 7253566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of amyloid proteins with protease I from Aspergillus oryzae. In vivo increase in SAA clearance rate after enzyme infusion.
    Skogen B; Amundsen E
    Scand J Immunol; 1982 Dec; 16(6):509-14. PubMed ID: 6760382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo.
    Husebekk A; Skogen B; Husby G; Marhaug G
    Scand J Immunol; 1985 Mar; 21(3):283-7. PubMed ID: 3922050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of amyloid A precursor protein SAA by macrophage cell lines obtained from amyloid resistant and susceptible strains of mice.
    Ham D; Caouras V; Radzioch D; Gervais F
    Scand J Immunol; 1997 Apr; 45(4):354-60. PubMed ID: 9105421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model.
    Magy N; Benson MD; Liepnieks JJ; Kluve-Beckerman B
    Amyloid; 2007 Mar; 14(1):51-63. PubMed ID: 17453625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of amyloid proteins by different serine proteases.
    Skogen B; Natvig JB
    Scand J Immunol; 1981 Oct; 14(4):389-96. PubMed ID: 6461061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product.
    Westermark GT; Sletten K; Grubb A; Westermark P
    Am J Pathol; 1990 Aug; 137(2):377-83. PubMed ID: 2386201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium.
    Ishii W; Liepnieks JJ; Yamada T; Benson MD; Kluve-Beckerman B
    Amyloid; 2013 Jun; 20(2):61-71. PubMed ID: 23461622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of systemic AA amyloidosis in animals.
    Murakami T; Ishiguro N; Higuchi K
    Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of elastases associated with purified plasma membranes isolated from human monocytes and lymphocytes.
    Fuks A; Zucker-Franklin D; Franklin EC
    Biochim Biophys Acta; 1983 Jan; 755(2):195-203. PubMed ID: 6550498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the release of proteases from peripheral blood monocytes.
    Fuks A; Zucker-Franklin D; Franklin EC
    Scand J Immunol; 1981 Nov; 14(5):577-9. PubMed ID: 7038855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.